{"transactions":[{"id":979322,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":72164,"kind":"person","name":"Trout Harry R. III","position":1,"cik":"0002085123","reported_name":"Trout Harry R. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-05T23:47:53.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":542,"price":14.23,"value":7712.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit awards granted on November 23, 2022 and November 22, 2023, as required pursuant to the terms of the award. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $13.89 to $14.46, inclusive. The reporting person undertakes to provide to Enanta Pharmaceuticals, Inc., any security holder of Enanta Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":16348,"source":{"system":"sec-edgar","filing":"0002064832-25-000067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000206483225000067/form4.xml","form_type":"4"}},{"id":982054,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":72164,"kind":"person","name":"Trout Harry R. III","position":1,"cik":"0002085123","reported_name":"Trout Harry R. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-03T22:05:25.000Z","date":"2025-12-02","kind":"sale","planned":false,"acquired":false,"shares":380,"price":13.96,"value":5304.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 27, 2024, as required pursuant to the terms of the award. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":16890,"source":{"system":"sec-edgar","filing":"0002064832-25-000050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000206483225000050/form4.xml","form_type":"4"}},{"id":982053,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":72164,"kind":"person","name":"Trout Harry R. III","position":1,"cik":"0002085123","reported_name":"Trout Harry R. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-03T22:05:25.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":105,"price":14.12,"value":1482.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 19, 2021."}],"balance_after":17270,"source":{"system":"sec-edgar","filing":"0002064832-25-000050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000206483225000050/form4.xml","form_type":"4"}},{"id":987434,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":72164,"kind":"person","name":"Trout Harry R. III","position":1,"cik":"0002085123","reported_name":"Trout Harry R. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-26T22:20:59.000Z","date":"2025-11-25","kind":"grant","planned":false,"acquired":true,"shares":12925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 25, 2025)."}],"balance_after":12925,"derivative":{"exercise_price":13.66,"expiration_date":"2035-11-25","underlying":"Common Stock","underlying_shares":12925},"source":{"system":"sec-edgar","filing":"0002064832-25-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000206483225000036/form4.xml","form_type":"4"}},{"id":987433,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":72164,"kind":"person","name":"Trout Harry R. III","position":1,"cik":"0002085123","reported_name":"Trout Harry R. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T22:20:59.000Z","date":"2025-11-25","kind":"grant","planned":false,"acquired":true,"shares":6463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Enanta Pharmaceuticals, Inc. (\"Enanta\") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Enanta common stock. The RSUs will vest and settle with respect to 25% of the award on December 1, 2026 and in substantially equal annual installments over the next three anniversaries thereafter."}],"balance_after":17375,"source":{"system":"sec-edgar","filing":"0002064832-25-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000206483225000036/form4.xml","form_type":"4"}}]}